Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $3.8 million.

  • Harvard Bioscience's Other Non-Current Assets rose 2971.96% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 2971.96%. This contributed to the annual value of $2.8 million for FY2024, which is 5623.36% down from last year.
  • Latest data reveals that Harvard Bioscience reported Other Non-Current Assets of $3.8 million as of Q3 2025, which was up 2971.96% from $3.8 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Other Non-Current Assets high stood at $8.7 million for Q2 2022, and its period low was $724000.0 during Q3 2021.
  • Over the past 5 years, Harvard Bioscience's median Other Non-Current Assets value was $4.8 million (recorded in 2024), while the average stood at $4.8 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 6181.43% in 2021, then soared by 104723.76% in 2022.
  • Harvard Bioscience's Other Non-Current Assets (Quarter) stood at $5.4 million in 2021, then skyrocketed by 44.74% to $7.8 million in 2022, then dropped by 16.8% to $6.5 million in 2023, then tumbled by 56.23% to $2.8 million in 2024, then soared by 33.89% to $3.8 million in 2025.
  • Its Other Non-Current Assets stands at $3.8 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.5 million for Q1 2025.